Vaccines, Blood & Biologics

Wilate

STN:  BL 125251
Proper Name: von Willebrand Factor/Coagulation Factor VIII Complex (Human)
Tradename: Wilate
Manufacturer: Octapharma Pharmazeutika Produktionsges.m.b.H., License #1646

Indication:

  • for the treatment of spontaneous or trauma-induced bleeding episodes in patients with severe von Willebrand disease (VWD) as well as patients with mild or moderate VWD in whom the use of desmopressin is known or suspected to be ineffective or contraindicated.

Related Information

  • FDA Online Label Repository
    Search this database for drug labeling and other information. The content has not been altered or verified by the FDA and may not be the labeling on currently distributed products or identical to the labeling that is approved.

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002

Page Last Updated: 11/20/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.